Fed. Circ. Nixes $15.7M Award In Blood Device IP Suit
The U.S. Court of Appeals for the Federal Circuit on Wednesday vacated a $15.7 million judgment in favor of Haemonetics Corp. in its suit against rival blood processing technology company Fenwal...To view the full article, register now.
Already a subscriber? Click here to view full article